Survivorship Best Practices

Webinars published on January 11, 2017 in American Cancer Society, Survivorship

Program Description:

This is part three of a free, interactive three-part webinar series on Survivorship hosted by the American Cancer Society. The webinars will include information about the Commission on Cancer survivorship care planning standard and the role of National Cancer Database data, review of the newly released American Cancer Society cancer survivorship care guidelines and a presentation by healthcare systems implementing survivorship programs.

Presenters:

Debra Spoljaric, RN, MSN, CPNP, FNP-C
Survivorship Program Manager
Siteman Cancer Center
Washington University School of Medicine

Sigrun Hallmeyer, MD
Chair, Cancer Committee, Advocate Lutheran General Hospital (ALGH)
Medical Director, ALGH Survivorship Program
Director, Oncology Specialists Research Institute

Related Items
Acute Survivorship
Kimberlee Rowett, DNP (c), MSN, MBA, RN
Webinars published on July 3, 2024 in Survivorship
Stages of Survivorship: Extended Survivorship
Jason King, RN, BSN, OCN
Webinars published on July 3, 2024 in Survivorship
The objectives of this webinar session are:
  • Define the “extended” survivorship phase.
  • Review cancer survivor facts and figures.
  • Identify immediate effects of cancer treatment.
  • Identify strategies for addressing the unique needs of cancer survivors in this stage.
  • Discuss the navigator’s role in evaluating, assessing, and planning follow-up care.
Stages of Survivorship: Permanent/Long-Term Survivorship
Megan Solinger, MHS, MA, OPN-CG, Pam Plasket, RN, BSN, OCN, CHPN
Webinars published on July 3, 2024 in Survivorship
The objectives of this webinar session are:
  • Define the “permanent/long-term” survivorship phase
  • Review cancer survivor facts and figures
  • Identify the prevalent concerns/needs of survivors in this phase
  • Identify strategies to address survivor needs in this phase
  • Discuss navigator’s role in evaluating, assessing and planning follow-up care
  • Discuss special considerations for the AYA and transplant population in this phase